Autonomic nervous system drugs

1,4-Dioxa-spiro[4.5]dec-8-ylamine.

1,5-Dibromopentane-d10

1-(1,2,3,4-tetrahydroisoquinolin-3-yl)ethanol.

1-(1-ADAMANTANECARBONYL)MORPHOLINE-

1-(2 2-DIBROMOVINYL)-7 7-DIMETHYLBICYCLO[2.2.

1-(2 3-DIHYDROXYBENZYLIDENE)SEMICARBAZIDE-

1-(2 4-DINITROANILINO)-2 5-PYRROLIDINEDIONE-

CAS: 115761-79-0 MDL No: MFCD00082588 UN No: UN2923 Haz Class: 8 (6.1) Packing Group: II Crystalline/Powder Molecular Formula: C₁₀H₁₂F₂N₂ MW: 198.22

1-(2-Aminophenyl)pyrrole participates in Pt(IV)-catalyzed hydroamination triggered cyclization reaction to yield fused pyrrolo [1,2- a ] quinoxalines . It reacts with aromatic or heteroaromatic aldehydes in ethanol and catalytic amounts of acetic

1-(2-Aminophenyl)pyrrole participates in Pt(IV)-catalyzed hydroamination triggered cyclization reaction to yield fused pyrrolo [1,2- a ] quinoxalines . It reacts with aromatic or heteroaromatic aldehydes in ethanol and catalytic amounts of acetic

Application PK 11195 has been used as an inhibitor of peripheral benzodiazepine receptor (PBR) homologs in primitive erythrocytes of embryos and in osteosarcoma cytoplasmic hydrids. It has also been used as an unlabelled competitive binder in in

Application PK 11195 has been used as an inhibitor of peripheral benzodiazepine receptor (PBR) homologs in primitive erythrocytes of embryos and in osteosarcoma cytoplasmic hydrids. It has also been used as an unlabelled competitive binder in in